Cite
Reply from Authors re: Stacy Loeb. Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening. Eur Urol 2012;61:875–6
MLA
Ørsted, David D., et al. “Reply from Authors Re: Stacy Loeb. Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening. Eur Urol 2012;61:875–6.” European Urology, vol. 61, no. 5, May 2012, pp. 876–77. EBSCOhost, https://doi.org/10.1016/j.eururo.2011.12.022.
APA
Ørsted, D. D., Nordestgaard, B. G., Jensen, G. B., Schnohr, P., & Bojesen, S. E. (2012). Reply from Authors re: Stacy Loeb. Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening. Eur Urol 2012;61:875–6. European Urology, 61(5), 876–877. https://doi.org/10.1016/j.eururo.2011.12.022
Chicago
Ørsted, David D., Børge G. Nordestgaard, Gorm B. Jensen, Peter Schnohr, and Stig E. Bojesen. 2012. “Reply from Authors Re: Stacy Loeb. Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening. Eur Urol 2012;61:875–6.” European Urology 61 (5): 876–77. doi:10.1016/j.eururo.2011.12.022.